Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;12(6):385-390.
doi: 10.1159/000485737. Epub 2017 Dec 12.

Is Mastectomy Oncologically Safer than Breast-Conserving Treatment in Early Breast Cancer?

Fabian Riedel  1 , André Hennigs  1 , Sarah Hug  1 , Benedikt Schaefgen  1 , Christof Sohn  1 , Florian Schuetz  1 , Michael Golatta  1 , Jörg Heil  1
Affiliations
Review

Is Mastectomy Oncologically Safer than Breast-Conserving Treatment in Early Breast Cancer?

Fabian Riedel et al. Breast Care (Basel). 2017 Dec.

Abstract

Aim: To describe and discuss the evidence for oncological safety of different procedures in oncological breast surgery, i.e. breast-conserving treatment versus mastectomy.

Methods: Literature review and discussion.

Results: Oncological safety in breast cancer surgery has many dimensions. Breast-conserving treatment has been established as the standard surgical procedure for primary breast cancer and fits to the preferences of most breast cancer patients concerning oncological safety and aesthetic outcome.

Conclusions: Breast-conserving treatment is safe. Nonetheless, the preferences of the individual patients in their consideration of breast conservation versus mastectomy should be integrated into routine treatment decisions.

Keywords: Breast cancer; Breast-conserving therapy; Mastectomy; Surgery; Surgical therapy.

PubMed Disclaimer

References

    1. Hennigs A, Riedel F, Gondos A, Sinn P, Schirmacher P, Marmé F, Jäger D, Kauczor H-U, Stieber A, Lindel K, Debus J, Golatta M, Schütz F, Sohn C, Heil J, Schneeweiss A. Prognosis of breast cancer molecular subtypes in routine clinical care: a large prospective cohort study. BMC Cancer. 2016;16:734. - PMC - PubMed
    1. Moossdorff M, van Roozendaal LM, Schipper RJ, Strobbe LJ, Voogd AC, Tjan-Heijnen VC, Smidt ML. Inconsistent selection and definition of local and regional endpoints in breast cancer research. Br J Surg. 2014;101:1657–1665. - PubMed
    1. Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, A'Hern R, Bliss J, Bogaerts J, Bonnefoi H, Brain E, Cardoso MJ, Chibaudel B, Coleman R, Cufer T, Dal Lago L, Dalenc F, De Azambuja E, Debled M, Delaloge S, Filleron T, Gligorov J, Gutowski M, Jacot W, Kirkove C, MacGrogan G, Michiels S, Negreiros I, Offersen BV, Penault Llorca F, Pruneri G, Roche H, Russell NS, Schmitt F, Servent V, Thurlimann B, Untch M, van der Hage JA, van Tienhoven G, Wildiers H, Yarnold J, Bonnetain F, Mathoulin-Pelissier S, Bellera C, Dabakuyo-Yonli TS. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) Ann Oncol. 2015;26:873–879. - PubMed
    1. Curran D, van Dongen JP, Aaronson NK, Kiebert G, Fentiman IS, Mignolet F, Bartelink H. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG) Eur J Cancer. 1998;34:307–314. - PubMed
    1. Chen CM, Cano SJ, Klassen AF, King T, McCarthy C, Cordeiro PG, Morrow M, Pusic AL. Measuring quality of life in oncologic breast surgery: a systematic review of patient-reported outcome measures. Breast J. 2010;16:587–597. - PubMed

LinkOut - more resources